Latest news
Tafinlar Plus Mekinist Triples Progression-Free Survival in Thyroid Cancer - Cure TodayCure Today · Fri, 31 Jul 2026 17:38:16 GMTDabrafenib Plus Trametinib Improves Progression-Free Survival in BRAF V600E-Positive Differentiated Thyroid Cancer - The ASCO PostThe ASCO Post · Mon, 27 Jul 2026 14:48:53 GMT